Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
about
USP2-45 Is a Circadian Clock Output Effector Regulating Calcium Absorption at the Post-Translational LevelAutosomal-Recessive Mutations in SLC34A1 Encoding Sodium-Phosphate Cotransporter 2A Cause Idiopathic Infantile HypercalcemiaGenetic testing in steroid-resistant nephrotic syndrome: when and how?Response of Npt2a knockout mice to dietary calcium and phosphorus.Exploring the genetic basis of early-onset chronic kidney disease.The Vacuolar H+-ATPase B1 Subunit Polymorphism p.E161K Associates with Impaired Urinary Acidification in Recurrent Stone Formers.[Stone treatment tomorrow and the day after].Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or NephrocalcinosisMutations in SLC26A1 Cause NephrolithiasisActualizing the Benefits of Genomic Discovery in Pediatric Nephrology.Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population HealthAnalysis of altered microRNA expression profiles in the kidney tissues of ethylene glycol-induced hyperoxaluric ratsHow should patients with cystine stone disease be evaluated and treated in the twenty-first century?Tubular and genetic disorders associated with kidney stones.Progress in Understanding the Genetics of Calcium-Containing Nephrolithiasis.Evidence for epistatic interaction between VDR and SLC13A2 genes in the pathogenesis of hypocitraturia in recurrent calcium oxalate stone formers.Loss of function of NaPiIIa causes nephrocalcinosis and possibly kidney insufficiency.Successful treatment of hypercalcaemia associated with a CYP24A1 mutation with fluconazole.The search for monogenic causes of kidney stones.Utility and limitations of animal models for the functional validation of human sequence variants.Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis.PDE1A polymorphism contributes to the susceptibility of nephrolithiasis.Genomic medicine for kidney disease.Genetic mutational testing of Chinese children with familial hematuria with biopsy‑proven FSGS.Refining Diagnostic Approaches in Nephrolithiasis: Incomplete Distal Renal Tubular Acidosis.A novel CYP24A1 genotype associated to a clinical picture of hypercalcemia, nephrolithiasis and low bone mass.Renal phosphate handling and inherited disorders of phosphate reabsorption: an update.Personalized Intervention in Monogenic Stone Formers.Update on Hereditary Kidney Stone Disease and Introduction of a New Clinical Patient Registry in Germany.Clinical, biochemical, and pathophysiological analysis of SLC34A1 mutations.
P2860
Q27334789-71187F66-868C-4296-BB8B-38C53D92199BQ28118903-06535263-2448-4DBE-BFA8-493B5A5F23EEQ33361808-92628391-FAC5-4D6A-9873-ADFE8BDA8FF4Q33610690-DF6D59DD-899B-4297-A0EB-6C40C96AABCBQ34508359-6344BFD2-8BD0-4577-9786-ACB44A55D506Q35802404-2244C232-299E-4FA5-B1F1-B12D7BDF810AQ36130679-5DDF577C-F43E-4255-B948-D5E22DDFBF18Q36770875-494BDE32-AF48-4883-BA11-B5B2BD14D4FAQ37004961-9AB128D8-F74F-4E73-BD88-A364B7185E2AQ37032683-57E7F0D4-0A68-4CD5-80E8-50C1ACC197BCQ37070036-7440FC17-70A3-4447-A0E7-8866FC4B2DDCQ37403598-AF100056-A79B-41DA-BF5B-8A24A4FFB5F9Q38650736-AC8E6A9A-0CC6-49A0-A5D7-0F503B798A53Q39023120-8263F674-C802-4A6B-AB75-1CBB9A845DD2Q39033649-1D2C2A94-67D5-42DE-A686-2E4058D3EDC5Q39378429-01A359E4-7E64-4BAF-AB25-C1917E38A587Q39632192-D87DED28-642C-4C2E-B165-2927679E67ECQ42392666-F2AC003D-91FE-49CA-93A5-9AB9C97F641EQ43163915-A54541A1-E165-4633-B512-FA46F05CABBEQ43238279-FD4D4E50-D325-424D-B935-3B7BA2051F59Q46964230-8AD2EB84-5BCD-444F-9EBA-9AAAEB2A0519Q47097882-B6402AB7-203E-40FF-A985-753F605160BAQ47200436-0B76DFC9-E200-4E4A-83B3-666AF41B8E46Q47401355-54CB8DCD-0D05-4CD2-A5D5-82DD703E83B1Q47807231-7D9054A8-7200-4D5B-8D7C-8B9A1814BD59Q48349461-C2AB4860-5925-49BA-BF97-FC570013FE27Q48351063-8480FC99-B0D3-4DA5-926C-02FE10C187ACQ50072674-94870011-6930-47D4-83C2-DF94B1F2EF3BQ52643458-1E7F922D-683D-42D3-BED9-7DF52ED0F06CQ55350639-A54E50C3-C5E1-498A-8BB9-61378AED3582
P2860
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
@ast
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
@en
type
label
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
@ast
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
@en
prefLabel
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
@ast
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis.
@en
P2093
P2860
P50
P356
P1476
Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis
@en
P2093
Ann Marie Hynes
Brittany Fisher
Caleb P Nelson
David T Thwaites
Friedhelm Hildebrandt
Jan Halbritter
John A Sayer
Jonathan D Porath
Leslie Spaneas
Michelle Baum
P2860
P304
P356
10.1681/ASN.2014040388
P577
2014-10-08T00:00:00Z